These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 9541183)

  • 21. Insulin-like growth factor, nephrogenesis and hypertension.
    Ashton N
    J Hypertens; 2006 Sep; 24(9):1707-9. PubMed ID: 16915017
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effects of lovastatin on renal function and expression of phosphorylating-p38 mitogen-activated protein kinase in experimental diabetic nephropathy in rats].
    Wang LH; Duan HJ; Shi YH; Liu QJ; He N; Liu SX
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Dec; 16(12):734-7. PubMed ID: 15585148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Glomerular lesions in adult patients].
    Colombat M; Deleuze S; Callard P
    Nephrol Ther; 2008 Dec; 4(7):617-27. PubMed ID: 18436496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glomerular changes in the KK-Ay/Ta mouse: a possible model for human type 2 diabetic nephropathy.
    Ito T; Tanimoto M; Yamada K; Kaneko S; Matsumoto M; Obayashi K; Hagiwara S; Murakoshi M; Aoki T; Wakabayashi M; Gohda T; Funabiki K; Maeda K; Horikoshi S; Tomino Y
    Nephrology (Carlton); 2006 Feb; 11(1):29-35. PubMed ID: 16509929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Controversies on the prevention of diabetic nephropathy.
    Chiarelli F; Verrotti A; Basciani F; di Ricco L; Sabatino G; Morgese G
    J Pediatr Endocrinol Metab; 1998 Apr; 11 Suppl 2():365-9. PubMed ID: 9642666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal effects of S18886 (Terutroban), a TP receptor antagonist, in an experimental model of type 2 diabetes.
    Sebeková K; Eifert T; Klassen A; Heidland A; Amann K
    Diabetes; 2007 Apr; 56(4):968-74. PubMed ID: 17267764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of diabetic nephropathy in mice by a diet low in glycoxidation products.
    Zheng F; He C; Cai W; Hattori M; Steffes M; Vlassara H
    Diabetes Metab Res Rev; 2002; 18(3):224-37. PubMed ID: 12112941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diabetic nephropathy and retinopathy.
    Jawa A; Kcomt J; Fonseca VA
    Med Clin North Am; 2004 Jul; 88(4):1001-36, xi. PubMed ID: 15308388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Can rodent models of diabetic kidney disease clarify the significance of early hyperfiltration?: recognizing clinical and experimental uncertainties.
    Levine DZ
    Clin Sci (Lond); 2008 Jan; 114(2):109-18. PubMed ID: 18062776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Different roles for TGF-beta and VEGF in the pathogenesis of the cardinal features of diabetic nephropathy.
    Ziyadeh FN
    Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S38-41. PubMed ID: 18842317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Podocyte detachment and reduced glomerular capillary endothelial fenestration in human type 1 diabetic nephropathy.
    Toyoda M; Najafian B; Kim Y; Caramori ML; Mauer M
    Diabetes; 2007 Aug; 56(8):2155-60. PubMed ID: 17536064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypertrophy and hyperfunction of the diabetic kidney.
    Hostetter TH
    J Clin Invest; 2001 Jan; 107(2):161-2. PubMed ID: 11160131
    [No Abstract]   [Full Text] [Related]  

  • 33. [The fate of podocytes in proteinuric nephropathies].
    Ortiz A; Marrón B; Ramos A
    Nefrologia; 2002; 22(5):425-31. PubMed ID: 12497743
    [No Abstract]   [Full Text] [Related]  

  • 34. Losartan ameliorates progression of glomerular structural changes in diabetic KKAy mice.
    Sasaki M; Uehara S; Ohta H; Taguchi K; Kemi M; Nishikibe M; Matsumoto H
    Life Sci; 2004 Jul; 75(7):869-80. PubMed ID: 15183078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The mechanisms underlying altered vascular resistance of glomerular afferent and efferent arterioles in diabetic nephropathy.
    Arima S; Ito S
    Nephrol Dial Transplant; 2003 Oct; 18(10):1966-9. PubMed ID: 13679465
    [No Abstract]   [Full Text] [Related]  

  • 36. [Renal histological lesions in patients with type II diabetes mellitus].
    Castellano I; Covarsí A; Novillo R; Gómez-Martino JR; Ferrando L
    Nefrologia; 2002; 22(2):162-9. PubMed ID: 12085417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diabetic nephropathy - Diagnostic].
    Hader C; Plum J
    Dtsch Med Wochenschr; 2002 Jun; 127(24):1324-7. PubMed ID: 12063665
    [No Abstract]   [Full Text] [Related]  

  • 38. The Authors Reply.
    Bock F; Shahzad K; Isermann B
    Kidney Int; 2015 Jul; 88(1):196-7. PubMed ID: 26126096
    [No Abstract]   [Full Text] [Related]  

  • 39. Improved renal function in diabetic patients with acute gout treated with anakinra.
    Balasubramaniam G; Almond M; Dasgupta B
    Kidney Int; 2015 Jul; 88(1):195-6. PubMed ID: 26126095
    [No Abstract]   [Full Text] [Related]  

  • 40. Diabetic kidney disease research: where do we stand at the turn of the century?
    Lee HB; Ha H; Kim SI; Ziyadeh FN
    Kidney Int Suppl; 2000 Sep; 77():S1-2. PubMed ID: 10997683
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.